GIVEHOPEpc

Could a vaccine be the answer to curing pancreatic cancer? A trial at the University of Cincinnati Cancer Center shows promise
It’s the same vaccine technology first used to prevent COVID-19, and it could be the next best treatment for pancreatic cancer patients.
The University of Cincinnati Cancer Center is the first in the Midwest to host this Phase 2 trial, open to pancreatic cancer patients who have not yet started treatment.
In the Phase 1 trial, eight out of 32 patients achieved complete cancer remission, promising a potential shift from the current low cure rates.
These exciting early results could be game-changing for pancreatic cancer patients across the country, and it is all happening right here at our Cancer Center.
For more information on the trial, please call 513-584-7698 or email [email protected]

PHOTO: Dr. Davendra Sohal, site principal investigator for pancreatic cancer vaccine trial

Next session is this Thursday, 6:30PM-7:30PM! Awareness and support is a continuous need. Register for this free series from UC Cancer Center and We Engage 4 Health.

Reducing Your Risk: Virtual Education for Cancer Survivors and Families Please click the link to complete this form.

We are beyond excited to be a part of the Cincinnati Gives Challenge hosted by Cincinnati Magazine
Challenge starts *TODAY*, Nov. 27th at 5pm through December 7th. Scan the QR code below or visit https://www.cincinnatigives.org/organization/Givehopepc to make your donation. ~Thank you ~

GIVEHOPEpc The all-volunteer GIVEHOPE Fund team raises money for pancreatic cancer research and awareness supporting the UC Pancreas Disease Team.